Table 3.

Adjusted (adjusted mean, 95% CI) FF AMH concentrations by tertiles of urinary phthalate metabolite concentrations among 138 women undergoing 179 IVF cycles in the EARTH Study.

	FF AMH levels, ng/mL			FF AMH levels, ng/mL

Range, ng/mL	Adjusted for Specific gravity (SG)	Adjusted for SG, age, BMI, race and protocol.	Range, ng/mL	Adjusted for SG	Adjusted for SG, age, BMI, race and protocol.

mEHP			mBP
T1 (0.35–0.90)	0.34 (0.17, 0.69)	0.32 (0.16, 0.63)	T1 (0.28–6.29)	0.43 (0.20, 0.90)	0.42 (0.20, 0.88)
T2 (0.94–2.34)	0.46 (0.23, 0.92)	0.46 (0.23, 0.90)	T2 (6.30–16.6)	0.31 (0.16, 0.62)	0.33 (0.17, 0.64)
T3 (2.40–102)	0.27 (0.14, 0.54)	0.28 (0.14, 0.56)	T3 (16.7–215)	0.32 (0.15, 0.67)	0.29 (0.14, 0.60)
T2-T3 (0.94–102)	0.35 (0.21, 0.58)	0.36 (0.22, 0.59)	T2-T3 (6.30–215)	0.32 (0.19, 0.52)	0.31 (0.19, 0.51)
mEHHP			miBP
T1 (0.56–5.92)	0.44 (0.22, 0.90)	0.41 (0.21, 0.83)	T1 (0.14–5.13)	0.47 (0.22, 0.99)	0.46 (0.22, 0.95)
T2 (6.01–13.9)	0.37 (0.19, 0.75)	0.36 (0.18, 0.72)	T2 (5.16–13.1)	0.35 (0.17, 0.70)	0.37 (0.19, 0.73)
T3 (14.0–317)	0.25 (0.12, 0.51)	0.27 (0.13, 0.54)	T3 (13.2–86.6)	0.26 (0.12, 0.53)	0.23 (0.11, 0.47)
T2-T3 (6.01–317)	0.31 (0.19, 0.51)	0.31 (0.19, 0.51)	T2-T3 (5.16–86.6)	0.30 (0.18, 0.50)	0.30 (0.18, 0.49)
mEOHP			mEP
T1 (0.30–4.04)	0.77 (0.38, 1.56)	0.72 (0.36, 1.44)	T1 (0.80–19.0)	0.56 (0.28, 1.11)	0.53 (0.27, 1.05)
T2 (4.13–9.81)	0.24 (0.12, 0.47)^*	0.23 (0.12, 0.45)^*	T2 (19.3–63.1)	0.22 (0.11, 0.44)^‡	0.22 (0.11, 0.43)^‡
T3 (9.90–235)	0.23 (0.11, 0.47)^*	0.24 (0.12, 0.48)^*	T3 (65.2–2610)	0.34 (0.17, 0.68)	0.35 (0.18, 0.68)
T2-T3 (4.13–235)	0.23 (0.14, 0.38)^*	0.23 (0.14, 0.38)^*	T2-T3 (19.3–2610)	0.28 (0.17, 0.45)^‡	0.28 (0.17, 0.44)^‡
mECPP			mBzP
T1 (1.51–10.3)	0.58 (0.28, 1.18)	0.56 (0.28, 1.13)	T1 (0.21–1.77)	0.61 (0.30, 1.24)	0.57 (0.28, 1.15)
T2 (10.4–23.0)	0.30 (0.15, 0.58)	0.28 (0.15, 0.55)	T2 (1.78–5.88)	0.28 (0.14, 0.57)	0.28 (0.14, 0.56)
T3 (23.1–338)	0.24 (0.12, 0.50)^‡	0.25 (0.12, 0.51)^‡	T3 (6.00–136)	0.24 (0.12, 0.49)^‡	0.24 (0.12, 0.50)^‡
T2-T3 (10.4–338)	0.27 (0.16, 0.44)^‡	0.27 (0.16, 0.43)^‡	T2-T3 (1.78–136)	0.26 (0.16, 0.43)^‡	0.26 (0.16, 0.43)^‡
∑DEHP			∑non-DEHP
T1 (0.01–0.07)	0.54 (0.27, 1.10)	0.50 (0.25, 1.01)	T1 (0.01–0.19)	0.62 (0.31, 1.24)	0.58 (0.29, 1.15)
T2 (0.08–0.16)	0.25 (0.12, 0.49)^‡	0.24 (0.12, 0.48)^‡	T2 (0.20–0.54)	0.19 (0.10, 0.39)^*	0.20 (0.10, 0.39)^*
T3 (0.17–3.34)	0.32 (0.15, 0.65)	0.33 (0.16, 0.68)	T3 (0.55–13.8)	0.35 (0.18, 0.69)	0.35 (0.18, 0.68)
T2-T3 (0.08–3.34)	0.28 (0.217 0.46)^‡	0.28 (0.17, 0.46)^‡	T2-T3 (0.20–13.8)	0.26 (0.16, 0.43)^‡	0.26 (0.16, 0.43)^‡

p-value < 0.05 when comparing that tertile/group with the lowest tertile/group.

^‡

p-value < 0.10 when comparing that tertile/group with the lowest tertile/group.